Public Health Trace republishes official recall, outbreak, and surveillance data from CDC, FDA, USDA, WHO, and other public sources. It is an independent information service, not a medical provider, and not a substitute for professional medical advice or your local public health department's own guidance.
Please review the following before continuing:
Policy version 2026-07-21, effective July 21, 2026.
Based on the official records currently available to Public Health Trace, no recalls naming Akebia Therapeutics dba Keryx Biopharmaceutials, Inc are currently shown as ongoing. The 2 records below are historical recall records.
Public Health Trace has 2 recalls naming Akebia Therapeutics dba Keryx Biopharmaceutials, Inc as the recalling firm, republished from official FDA and USDA sources.
A bar chart of the number of recalls naming this company by year.
| Year | Recalls |
|---|---|
| 2020 | 1 |
| 2021 | 1 |
FDA Recall TerminatedTerminated: February 10, 2022Historical recordClass III
FDA Recall TerminatedTerminated: September 1, 2021Historical recordClass II
Showing 1–2 of 2 results
Some FDA recall records on this page come from FDA's Enforcement Report database. Not every Enforcement Report record has a separate FDA.gov recall-announcement page.
This page lists recalls that name Akebia Therapeutics dba Keryx Biopharmaceutials, Inc as the recalling firm in the official source notice. It is not a safety rating, ranking, or statement that the company acted negligently. Read the full medical disclaimer.
